Xose S. Puente

Xose S. Puente

Auto-generated profile, based on publicly available information

Xose S. Puente

Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2013 in Nature
Verified
Journal Article
Open access
PDF file
AIAustralian Pancreatic Cancer Genome Initiative
Australian Pancreatic Cancer Genome Initiative
LALudmil B. Alexandrov
Ludmil B. Alexandrov
ICICGC Breast Cancer Consortium
ICGC Breast Cancer Consortium
ICICGC MMML-Seq Consortium
ICGC MMML-Seq Consortium
IPICGC PedBrain
ICGC PedBrain
MSMichael R. Stratton
Michael R. Stratton
All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, ‘kataegis’, is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.

5 June 2011 in Nature
Verified
Journal Article
Open access
PDF file
XPXose S. Puente
Xose S. Puente
MPMagda Pinyol
Magda Pinyol
VQVíctor Quesada
Víctor Quesada
LCLaura Conde
Laura Conde
GOGonzalo R. Ordóñez
Gonzalo R. Ordóñez
ECElías Campo
Elías Campo
Analysis of the genomes of four patients with chronic lymphocytic leukaemia, and validation in more than 300 patients, has identified four genes — NOTCH1, MYD88, XPO1 and KLHL6 — that are recurrently mutated in the condition. Mutations in NOTCH1, MYD88 and XPO1 are thought to contribute to the clinical evolution of the disease. Evidence that NOTCH1 and MYD88 mutations are activating events highlights them as potential therapeutic targets. Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western countries, is a heterogeneous disease with variable clinical presentation and evolution1,2. Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes3,4. The molecular changes leading to the pathogenesis of the disease are still poorly understood. Here we performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88) and kelch-like 6 (KLHL6). Mutations in MYD88 and KLHL6 are predominant in cases of CLL with mutated immunoglobulin genes, whereas NOTCH1 and XPO1 mutations are mainly detected in patients with unmutated immunoglobulins. The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease. To our knowledge, this is the first comprehensive analysis of CLL combining whole-genome sequencing with clinical characteristics and clinical outcomes. It highlights the usefulness of this approach for the identification of clinically relevant mutations in cancer.

11 December 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VQVíctor Quesada
Víctor Quesada
LCLaura Conde
Laura Conde
NVNeus Villamor
Neus Villamor
GOGonzalo R Ordóñez
Gonzalo R Ordóñez
PJPedro Jares
Pedro Jares
CLCarlos López-Otín
Carlos López-Otín

22 July 2015 in Nature
Verified
Journal Article
Closed access
PDF file
XPXose S. Puente
Xose S. Puente
SBSilvia Beà
Silvia Beà
RVRafael Valdés-Mas
Rafael Valdés-Mas
NVNeus Villamor
Neus Villamor
JGJesús Gutiérrez-Abril
Jesús Gutiérrez-Abril
ECElías Campo
Elías Campo

1 April 2010 in Nature
Verified
Journal Article
Open access
PDF file
WWWesley C. Warren
Wesley C. Warren
DCDavid F. Clayton
David F. Clayton
HEHans Ellegren
Hans Ellegren
AAArthur P. Arnold
Arthur P. Arnold
LHLaDeana W. Hillier
LaDeana W. Hillier
RWRichard K. Wilson
Richard K. Wilson
The genome of the zebra finch — a songbird and a model for the study of vertebrate brain, behaviour and evolution — has been sequenced. Its comparison with the chicken genome, the only other bird genome available, shows that genes with neural function and implicated in cognitive processing of song have been rapidly evolving in the finch lineage. The study also shows that vocal communication engages much of the zebra finch brain transcriptome and identifies a potential integrator of microRNA signals linked to vocal communication. The genome of the zebra finch — a songbird and a model for studying the vertebrate brain, behaviour and evolution — has been sequenced. Comparison with the chicken genome, the only other bird genome available, shows that genes that have neural function and are implicated in the cognitive processing of song have been evolving rapidly in the finch lineage. Moreover, vocal communication engages much of the transcriptome of the zebra finch brain. The zebra finch is an important model organism in several fields1,2 with unique relevance to human neuroscience3,4. Like other songbirds, the zebra finch communicates through learned vocalizations, an ability otherwise documented only in humans and a few other animals and lacking in the chicken5—the only bird with a sequenced genome until now6. Here we present a structural, functional and comparative analysis of the genome sequence of the zebra finch (Taeniopygia guttata), which is a songbird belonging to the large avian order Passeriformes7. We find that the overall structures of the genomes are similar in zebra finch and chicken, but they differ in many intrachromosomal rearrangements, lineage-specific gene family expansions, the number of long-terminal-repeat-based retrotransposons, and mechanisms of sex chromosome dosage compensation. We show that song behaviour engages gene regulatory networks in the zebra finch brain, altering the expression of long non-coding RNAs, microRNAs, transcription factors and their targets. We also show evidence for rapid molecular evolution in the songbird lineage of genes that are regulated during song experience. These results indicate an active involvement of the genome in neural processes underlying vocal communication and identify potential genetic substrates for the evolution and regulation of this behaviour.

1 July 2003 in Nature Reviews Genetics
Verified
Journal Article
Closed access
XPXose S. Puente
Xose S. Puente
LSLuis M. Sánchez
Luis M. Sánchez
COChristopher M. Overall
Christopher M. Overall
CLCarlos López-Otín
Carlos López-Otín